Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adult Immune Thrombocytopenia (ITP)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT03275740
What this trial is testing

A First in HumanTrial to Evaluate The Safety, Tolerability, And Pharmacokinetics Of PF-06755347

Who this might be right for
HealthyPrimary Immune ThrombocytopeniaPolyradiculoneuropathy, Chronic Inflammatory Demyelinating
Pfizer 58
Not applicableNot Yet RecruitingNCT07182760
What this trial is testing

Ultrasound to Detect Splenomegally in Patients With Isolated Thrombocytopenia

Who this might be right for
Primary Immune Thrombocytopenic PurpuraAmegakaryocytic AplasiaUnilineage Myelodysplastic Syndrome ( Megakaryocyte Dysplasia)+2 more
Assiut University 100
Large-scale testing (Phase 3)UnknownNCT06004856
What this trial is testing

Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Chronic Primary Immune Thrombocytopenia

Who this might be right for
Chronic Primary Immune Thrombocytopenia (ITP)
Beijing InnoCare Pharma Tech Co., Ltd. 195
Large-scale testing (Phase 3)Study completedNCT04687072
What this trial is testing

Evaluate the Efficacy and Safety of Efgartigimod PH20 Subcutaneous in Adult Patients With Primary Immune Thrombocytopenia

Who this might be right for
Primary Immune Thrombocytopenia
argenx 207
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07083739
What this trial is testing

A Study on the Safety and Efficacy of TQB3473 Tablets in the Treatment of Persistent or Chronic Primary Immune Thrombocytopenia (ITP) in Adults

Who this might be right for
Primary Immune Thrombocytopenia
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 320
Testing effectiveness (Phase 2)Looking for participantsNCT07039422
What this trial is testing

Study of Ianalumab in Adults With Primary Immune Thrombocytopenia (ITP) and Warm-antibody Autoimmune Hemolytic Anemia (wAIHA) Who Have Previously Benefited From Ianalumab

Who this might be right for
Primary Immune ThrombocytopeniaWarm Autoimmune Hemolytic Anemia
Novartis Pharmaceuticals 60
Testing effectiveness (Phase 2)Study completedNCT00621894
What this trial is testing

Oral LGD-4665 Versus Placebo in Adults With Immune Thrombocytopenic Purpura (ITP) for 6 Weeks Plus Open Treatment Continuation

Who this might be right for
Immune Thrombocytopenic Purpura
GlaxoSmithKline 23
Not applicableUnknownNCT01196884
What this trial is testing

Immune Thrombocytopenia (ITP) Immune-Genetic Assessment

Who this might be right for
Thrombocytopenia
Azienda Sanitaria-Universitaria Integrata di Udine 190
Testing effectiveness (Phase 2)Study completedNCT04669600
What this trial is testing

A Phase 2a Study Evaluating BIVV020 in Adults With Persistent/Chronic Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia (ITP)
Bioverativ, a Sanofi company 12
Post-approval studies (Phase 4)Study completedNCT01356511
What this trial is testing

High-dose Dexamethasone Versus Conventional Dose Prednisone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Purpura, Thrombocytopenic, Idiopathic
Shandong University 261
Testing effectiveness (Phase 2)UnknownNCT05459649
What this trial is testing

Combined Steroid and Cyclosporin as First-line Treatment in Adults With Primary Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 253
Testing effectiveness (Phase 2)Study completedNCT00162006
What this trial is testing

Efficacy and Safety Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Adult Subjects With Chronic Idiopathic Thrombocytopenic Purpura

Who this might be right for
Immune Thrombocytopenic Purpura (ITP)
Baxalta now part of Shire 28
Large-scale testing (Phase 3)Study completedNCT02334813
What this trial is testing

Daily Prednisone Versus Pulsed Dexamethasone in Treatment-naïve Adult Patients With Immune Thrombocytopenia

Who this might be right for
Purpura, Thrombocytopenic, Idiopathic
University Hospital, Essen 26
Early research (Phase 1)Looking for participantsNCT07605845
What this trial is testing

Safety and Efficacy of GL-2045 in Patients With Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Gliknik Inc. 42
Post-approval studies (Phase 4)Study completedNCT04638829
What this trial is testing

Safety and Treatment Satisfaction in Adults With Chronic ITP After Switching to Avatrombopag From Eltrombopag or Romiplostim

Who this might be right for
Immune Thrombocytopenia
Sobi, Inc. 60
Large-scale testing (Phase 3)Ended earlyNCT04224688
What this trial is testing

Assess the Efficacy, Safety, and Tolerability of Rozanolixizumab in Adult Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Primary Immune Thrombocytopenia
UCB Biopharma SRL 30
Testing effectiveness (Phase 2)UnknownNCT04703621
What this trial is testing

The DART Study- Daratumumab Treatment in ITP

Who this might be right for
ITP
Ostfold Hospital Trust 21
Large-scale testing (Phase 3)Study completedNCT04070599
What this trial is testing

Initial Hemato-immunological Profile on the Evolution of Immunological Thrombopenic Purpura.

Who this might be right for
Immune Thrombocytopenic PurpuraAutoimmune ThrombocytopeniaThrombopenia
University Hospital, Bordeaux 70
Post-approval studies (Phase 4)Study completedNCT01098487
What this trial is testing

A Longitudinal 2-year Bone Marrow Study of Eltrombopag in Previously Treated Adults, With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP)

Who this might be right for
Purpura, Thrombocytopaenic, Idiopathic
GlaxoSmithKline 167
Testing effectiveness (Phase 2)Study completedNCT06287567
What this trial is testing

Lusutrombopag in the Treatment of Immune Thrombocytopenia (ITP)

Who this might be right for
Idiopathic Thrombocytopenic PurpuraImmune Thrombocytopenia
Institute of Hematology & Blood Diseases Hospital, China 17
Next Page